Portfolio company
RetiSpec
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence software for retinal imaging to help clinicians detect biomarkers of Alzheimer's disease and other neurodegenerative conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Optina Diagnostics
This company develops artificial intelligence platforms and hyperspectral retinal imaging cameras to help eye specialists diagnose and manage retinal and neurodegenerative diseases.
Optina Dx
The company develops an artificial intelligence platform and retinal imaging camera for the non-invasive detection of Alzheimer's disease and other systemic conditions for healthcare providers.
Novoic
This company develops speech-based artificial intelligence software to help clinicians and researchers detect early-stage neurological diseases, including Alzheimer's and Parkinson's.
Neurovision
This company provides diagnostic blood tests and retinal imaging software to help healthcare providers detect and monitor neurodegenerative diseases.
Cognoptix
This company develops a non-invasive eye scanning system to detect Alzheimer's disease for clinicians and pharmaceutical partners.
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
Combinostics
This company develops AI software for quantifying brain images and patient data to support clinicians in diagnosing and managing neurological disorders.
AI4Eyes Medical Technologies
This company develops artificial intelligence software and imaging hardware for eye care professionals to diagnose and manage ocular diseases.
